Session (CTI)

This session examines how health economic evidence is translated into real-world decisions for medical devices and diagnostics across the technology lifecycle. Presentations span early health economic modeling under uncertainty, methodological standards for device HTA, budget impact and affordability analyses, and broader system-level implications. Together, the session illustrates how decision-relevant economic evidence can meaningfully inform HTA, payer, provider, and procurement decisions for non-pharmaceutical technologies.